Physician profile
Edwin M Johnson
NPI 1598732224
$1,573.54
in general payments reported to CMS, 2019-2025
16 companies · $30.95 in 2025
The $30.95 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $156 · 2022: $16.28 · 2023: $111 · 2024: $353 · 2025: $30.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $342.05 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.04 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $195.06 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $189.29 | 2019-2024 | |
| Boston Scientific Corporation | $94.80 | 2024 | Watchman Flx |
| Pfizer INC. | $90.56 | 2019-2024 | |
| Gilead Sciences, INC. | $70.46 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $61.44 | 2019-2024 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $58.60 | 2019-2025 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $56.27 | 2019 | |
| Medtronic Vascular, INC. | $47.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.39 | 2019-2024 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $37.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.53 | 2019 | |
| Amarin Pharma, INC. | $29.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $15.28 | 2025 | Ecc Solutions |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.